Skip to main content
Premium Trial:

Request an Annual Quote

BioBase Signs Celera, Exelixis, Clontech for Access to Transfac Database

NEW YORK, April 18 – Celera, Clontech Laboratories, and Exelixis have subscribed to BioBase’s Transfac Professional database of transcription factors and regulation, the company said Wednesday.

Under the terms of the agreement, Cognia, the North American distributor of Transfac Professional, will provide it along with Match, a new tool that allows users to locate transcription factor binding sites in sequences.

The companies did not disclose the financial terms of the agreements.

“Transfac Professional may help these researchers accelerate their discovery processes by helping them understand and navigate more efficiently through their research data,” said Holger Karas, CEO of BioBase.  

Transfac Professional is a relational database system of transcription information from plant, yeast, mouse, and human factors. BioBase, of Braunschweig, Germany has also added SNP information from the SNP consortium. BioBase continues to curate this database.

Other customers for Transfac include Eli Lilly, Schering-Plough Research Institute, Aventis Pharma, and the Akzo Nobel-subsidiary Organon.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.